# PDE6A

## Overview
The PDE6A gene encodes the alpha subunit of the rod-specific cyclic guanosine monophosphate (cGMP) phosphodiesterase, a critical enzyme in the phototransduction pathway of retinal photoreceptor cells. This enzyme, phosphodiesterase 6A (PDE6A), is a key player in the conversion of cGMP to 5′-GMP, thereby regulating cGMP levels and facilitating the transmission of visual signals. As a component of the phosphodiesterase 6 (PDE6) complex, PDE6A forms a heterotetramer with other subunits, including PDE6B and inhibitory PDE6G subunits, to execute its function in the visual transduction cascade. The protein's structure, characterized by GAF domains and a catalytic domain, allows it to interact with various proteins, such as the G protein transducin, to modulate its activity. Mutations in the PDE6A gene are linked to retinitis pigmentosa type 43 (RP43), highlighting its clinical significance in retinal health and disease (Irwin2019The; Maryam2019The; Occelli2017Gene).

## Structure
The PDE6A protein is a component of the phosphodiesterase 6 (PDE6) complex, which plays a critical role in the phototransduction pathway in retinal photoreceptor cells. The molecular structure of PDE6A includes several distinct domains. The N-terminal region contains two tandem GAF domains, GAF-A and GAF-B, which are involved in binding cyclic nucleotides and regulating the enzyme's activity (Gulati2019CryoEM; Maryam2019The). The C-terminal region houses the catalytic domain responsible for hydrolyzing cGMP, a key step in visual signal transduction (Maryam2019The).

The secondary structure of PDE6A is characterized by alpha-helices and beta-sheets, which contribute to its stability and function (Maryam2019The). The tertiary structure involves a linear organization of the GAF and catalytic domains, connected by long alpha helices, forming a trilobed architecture with pseudo-twofold symmetry (Gulati2019CryoEM).

In terms of quaternary structure, PDE6A forms a heterotetramer with other PDE6 subunits, specifically PDE6B and two inhibitory PDE6G subunits, contributing to its functional configuration in the photoreceptor cells (Cote2021Photoreceptor). Post-translational modifications such as prenylation and phosphorylation are common, affecting the protein's function and localization (Cote2021Photoreceptor).

## Function
The PDE6A gene encodes the α subunit of the phosphodiesterase 6 (PDE6) enzyme, which is primarily expressed in the cytosol of retinal photoreceptor cells. PDE6 plays a crucial role in the cyclic guanosine monophosphate (cGMP) signaling pathway by catalyzing the conversion of cGMP to 5′-GMP, thereby acting as a negative regulator of cGMP concentration. This regulation is essential for proper cellular function and signal transduction, particularly in the phototransduction cascade of vision (Mohamed1998Structure; Maryam2019The).

In the visual transduction pathway, PDE6 is activated by the G protein transducin upon light activation, leading to a decrease in cGMP levels. This reduction causes the closure of cGMP-gated ion channels, resulting in the hyperpolarization of photoreceptor cells and the transmission of visual signals to other retinal neurons (Irwin2019The; Cote2021Photoreceptor). The enzyme's activity is crucial for the homeostatic regulation of signals within various interlinked intracellular compartments, relying on the dynamic organization of multimeric signaling complexes (Maryam2019The).

PDE6A's function is vital for maintaining the balance of cGMP levels, which is necessary for normal photoreceptor function and other physiological processes, including the regulation of light-induced melatonin production in the pineal gland (Maryam2019The).

## Clinical Significance
Mutations in the PDE6A gene are associated with retinitis pigmentosa type 43 (RP43), a form of autosomal recessive retinitis pigmentosa (RP) that accounts for approximately 4% of such cases. RP is characterized by the degeneration of rod photoreceptors, leading to night blindness, followed by a gradual loss of cone photoreceptors, resulting in progressive vision loss and potentially legal blindness (Khateb2019Longitudinal; Occelli2017Gene). 

The PDE6A gene encodes the alpha subunit of the rod-specific cyclic guanosine monophosphate (cGMP) phosphodiesterase, which is crucial for the phototransduction cascade in rod photoreceptors. Mutations in PDE6A disrupt this process, leading to the accumulation of cGMP, which can cause photoreceptor cell death through mechanisms such as calcium/sodium imbalance and activation of cGMP-dependent protein kinase G (Khateb2019Longitudinal; Sothilingam2015Retinitis).

Several specific mutations in PDE6A, including missense, nonsense, and splice-site mutations, have been identified. These mutations are linked to varying degrees of retinal degeneration and are often associated with early-onset night blindness (Khateb2019Longitudinal; Li2022Novel). Gene supplementation therapy using adeno-associated viral vectors has shown promise in animal models, suggesting potential for future human clinical trials (Occelli2017Gene).

## Interactions
Phosphodiesterase 6A (PDE6A) is a subunit of the rod photoreceptor cGMP phosphodiesterase complex, which plays a critical role in the visual transduction pathway. PDE6A forms a heterodimer with PDE6B, and this catalytic dimer is regulated by the inhibitory γ-subunit (Pγ) (Irwin2019The). The interaction between PDE6A and Pγ is crucial for the regulation of PDE6 activity, as Pγ binds to two distinct sites on the αβ dimer, with the N-terminal half of Pγ binding with significantly higher affinity than the C-terminal region (Mou2001The).

PDE6A also interacts with the G protein transducin, specifically with its α-subunit (Gtα). The binding of Gtα to PDE6A is essential for the activation of PDE6, as it relieves the inhibition imposed by Pγ. This interaction involves the docking of Gtα to two nonidentical sites on the PDE6 catalytic domains, facilitating the release of the inhibitory constraint of Pγ and leading to full enzyme activation (Irwin2019The).

The structural interactions of PDE6A with other proteins are critical for its function in the phototransduction cascade, influencing the sensitivity and speed of the visual response in vertebrate photoreceptors (Irwin2019The).


## References


[1. (Mohamed1998Structure) Mohamed K. Mohamed, Russell E. Taylor, Douglas S. Feinstein, Xizhong Huang, and Steven J. Pittler. Structure and upstream region characterization of the human gene encoding rod photoreceptor cgmp phosphodiesterase α-subunit. Journal of Molecular Neuroscience, 10(3):235–250, June 1998. URL: http://dx.doi.org/10.1007/BF02761777, doi:10.1007/bf02761777. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/BF02761777)

[2. (Li2022Novel) Yuyu Li, Ruyi Li, Hehua Dai, and Genlin Li. Novel variants in pde6a and pde6b genes and its phenotypes in patients with retinitis pigmentosa in chinese families. BMC Ophthalmology, January 2022. URL: http://dx.doi.org/10.1186/s12886-021-02242-5, doi:10.1186/s12886-021-02242-5. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12886-021-02242-5)

[3. (Occelli2017Gene) Laurence M. Occelli, Christian Schön, Mathias W. Seeliger, Martin Biel, Stylianos Michalakis, Simon M. Petersen-Jones, and the RD-CURE Consortium. Gene supplementation rescues rod function and preserves photoreceptor and retinal morphology in dogs, leading the way toward treating humanpde6a-retinitis pigmentosa. Human Gene Therapy, 28(12):1189–1201, December 2017. URL: http://dx.doi.org/10.1089/hum.2017.155, doi:10.1089/hum.2017.155. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/hum.2017.155)

[4. (Khateb2019Longitudinal) Samer Khateb, Marco Nassisi, Kinga M. Bujakowska, Cécile Méjécase, Christel Condroyer, Aline Antonio, Marine Foussard, Vanessa Démontant, Saddek Mohand-Saïd, José-Alain Sahel, Christina Zeitz, and Isabelle Audo. Longitudinal clinical follow-up and genetic spectrum of patients with rod-cone dystrophy associated with mutations inpde6aandpde6b. JAMA Ophthalmology, 137(6):669, June 2019. URL: http://dx.doi.org/10.1001/jamaophthalmol.2018.6367, doi:10.1001/jamaophthalmol.2018.6367. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1001/jamaophthalmol.2018.6367)

[5. (Sothilingam2015Retinitis) Vithiyanjali Sothilingam, Marina Garcia Garrido, Kangwei Jiao, Elena Buena-Atienza, Ayse Sahaboglu, Dragana Trifunović, Sukirthini Balendran, Tanja Koepfli, Regine Mühlfriedel, Christian Schön, Martin Biel, Angelique Heckmann, Susanne C. Beck, Stylianos Michalakis, Bernd Wissinger, Mathias W. Seeliger, and François Paquet-Durand. Retinitis pigmentosa: impact of differentpde6apoint mutations on the disease phenotype. Human Molecular Genetics, 24(19):5486–5499, July 2015. URL: http://dx.doi.org/10.1093/hmg/ddv275, doi:10.1093/hmg/ddv275. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddv275)

[6. (Cote2021Photoreceptor) Rick H. Cote. Photoreceptor phosphodiesterase (pde6): activation and inactivation mechanisms during visual transduction in rods and cones. Pflügers Archiv - European Journal of Physiology, 473(9):1377–1391, April 2021. URL: http://dx.doi.org/10.1007/s00424-021-02562-x, doi:10.1007/s00424-021-02562-x. This article has 21 citations.](https://doi.org/10.1007/s00424-021-02562-x)

[7. (Maryam2019The) Arooma Maryam, Sundeep Chaitanya Vedithi, Rana Rehan Khalid, Ali F. Alsulami, Pedro Henrique Monteiro Torres, Abdul Rauf Siddiqi, and Tom L. Blundell. The molecular organization of human cgmp specific phosphodiesterase 6 (pde6): structural implications of somatic mutations in cancer and retinitis pigmentosa. Computational and Structural Biotechnology Journal, 17:378–389, 2019. URL: http://dx.doi.org/10.1016/j.csbj.2019.03.004, doi:10.1016/j.csbj.2019.03.004. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2019.03.004)

[8. (Irwin2019The) Michael J. Irwin, Richa Gupta, Xiong-Zhuo Gao, Karyn B. Cahill, Feixia Chu, and Rick H. Cote. The molecular architecture of photoreceptor phosphodiesterase 6 (pde6) with activated g protein elucidates the mechanism of visual excitation. Journal of Biological Chemistry, 294(51):19486–19497, December 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.011002, doi:10.1074/jbc.ra119.011002. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.011002)

[9. (Mou2001The) Hongmei Mou and Rick H. Cote. The catalytic and gaf domains of the rod cgmp phosphodiesterase (pde6) heterodimer are regulated by distinct regions of its inhibitory γ subunit. Journal of Biological Chemistry, 276(29):27527–27534, July 2001. URL: http://dx.doi.org/10.1074/jbc.m103316200, doi:10.1074/jbc.m103316200. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m103316200)

[10. (Gulati2019CryoEM) Sahil Gulati, Krzysztof Palczewski, Andreas Engel, Henning Stahlberg, and Lubomir Kovacik. Cryo-em structure of phosphodiesterase 6 reveals insights into the allosteric regulation of type i phosphodiesterases. Science Advances, February 2019. URL: http://dx.doi.org/10.1126/sciadv.aav4322, doi:10.1126/sciadv.aav4322. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aav4322)